论文部分内容阅读
Naturally occurring tubular halloysite is a potential drug carrier because of the significant deposit, unique mesoscopic (2-50 nm) or even macroscopic (>50 nm) lumen, and excellent biocompatibility. The drugs loaded on halloysite exhibited slow release under the diffusion limitation by the halloysite nanotube. However, due to the weak interaction between halloysite and guest, the loading capacity of halloysite was relatively low. This drawback severely limits the application of halloysite as carrier in pharmaceutics. In this study, the performance of halloysite as carrier for ibuprofen (IBU) loading was investigated for the first time. The effects of 3-aminopropyltriethoxysilane (APTES) modification and thermal treatment of halloysite on the loading and release of IBU were also studied. The purified halloysites were heated at 120 ℃ and 400 ℃ (labeled as Hal/120 and Hal/400), and then modified with APTES (labeled as Hal/120-A and Hal/400-A). The loading of IBU was achieved by soaking method (labeled as IBU-Hal/120, IBU-Hal/400, IBU-Hal/120-A, and IBU-Hal/400-A.). The in vitro drug delivery assays were performed in phosphate buffer solution. IBU was loaded mainly into the lumen and partially on the external surface of halloysite. The order of IBU contents was as follows: IBU-Hal/400-A (14.8wt%) > IBU-Hal/120-A (12.7wt%) > IBU-Hal/400 (11.8wt%) > IBU-Hal/120 (11.7wt%). The IBU was initially anchored to the surface hydroxyl groups of halloysite by hydrogen bonding, followed by further bonding of IBU with the anchored IBU to form hydrogen-bonded aggregates. The APTES modification of halloysite promoted the loading of IBU by introducing a strong affinity through electrostatic attraction between the introduced aminopropyl groups of APTES and the carboxyl groups of IBU. Thermal treatment at 400°C did not destroy the tubular morphology or the crystal structure of halloysite and had little effect on IBU loading in unmodified halloysite. However, thermal treatment by reducing water content in halloysite restricted the grafting of APTES in the lumen space, and further increased IBU loading. All IBU-loaded samples exhibit a burst release with a following slow release. However, owing to the strong electrostatic attraction in modified samples, the burst release was much more suppressed and the release rate was also lower than that in unmodified ones. The in vitro release profiles of the IBU-loaded samples were well fitted with the modified Korsmeyer-Peppas model. The IBU release mechanism of the unmodified samples was Fickian diffusion; however it was non-Fickian diffusion for the modified samples. The findings are of significance for broadening the use of halloysite as carrier for drugs and other active molecules in the pharmaceutical, pesticides, and coating industries.
Naturally occurring tubular halloysite is a potential drug carrier of the significant deposit, unique mesoscopic (2-50 nm) or even macroscopic (> 50 nm) lumen, and excellent biocompatibility. The drugs loaded on halloysite presenting slow release under the diffusion limitation by The halloysite nanotube. However, due to the weak interaction between halloysite and guest, the loading capacity of halloysite was relatively low. This drawback severely limits the application of halloysite as carrier in pharmaceutics. In this study, the performance of halloysite as carrier for ibuprofen (IBU) loading was investigated for the first time. The effects of 3-aminopropyltriethoxysilane (APTES) modification and thermal treatment of halloysite on the loading and release of IBU were also studied. The purified halloysites were heated at 120 ° C and 400 ° C as Hal / 120 and Hal / 400), and then modified with APTES (labeled as Hal / 120-A and Hal / 400- A). The loading of IBU was achieved by soakin g method (labeled as IBU-Hal / 120, IBU-Hal / 400, IBU-Hal / 120-A, and IBU-Hal / 400-A. The order of IBU contents was as follows: IBU-Hal / 400-A (14.8 wt%)> IBU-Hal / 120-A IBU-Hal / 400 (11.8 wt%)> IBU-Hal / 120 (11.7 wt%) The IBU was initially anchored to the surface hydroxyl groups of halloysite by hydrogen bonding, followed by further bonding of IBU with the anchored IBU to form hydrogen-bonded aggregates. The APTES modification of halloysite promoted the loading of IBU by introducing a strong affinity through electrostatic attraction between the amin aminopropyl groups of APTES and the carboxyl groups of IBU. Thermal treatment at 400 ° C did not destroy the tubular morphology or the crystal structure of halloysite and had little effect on IBU loading in unmodified halloysite. However, thermal treatment by redu cingwater content in halloysite restricted the grafting of APTES in the lumen space, and further increased IBU loading. However, owing to the strong electrostatic attraction in modified samples, the burst release was much more suppressed and the release rate was also lower than that in unmodified ones. The in vitro release profiles of the IBU-loaded samples were well fitted with the modified Korsmeyer-Peppas model. The IBU release mechanism of the unmodified samples was Fickian diffusion ; however it was non-Fickian diffusion for the modified samples. The findings are of significance for broadening the use of halloysite as carrier for drugs and other active molecules in the pharmaceutical, pesticides, and coating industries.